Fletcher Payne's most recent trade in Aptose Biosciences Inc was a trade of 1,000,000 Common Stock (Option) done . Disclosure was reported to the exchange on June 30, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aptose Biosciences Inc | Fletcher Payne | FORMER SVP AND CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2026 | 1,000,000 | 0 | - | - | Common Stock (Option) | |
| Aptose Biosciences Inc | Fletcher Payne | FORMER SVP AND CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2026 | 200,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Aptose Biosciences Inc | Fletcher Payne | FORMER SVP AND CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Jun 2026 | 55,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Aptose Biosciences Inc | Fletcher Payne | FORMER SVP AND CFO | Sale or transfer of securities back to the company at price $ 1.72 per share. | 30 Jun 2026 | 222 | 0 (0%) | 0% | 1.7 | 382 | Common Shares |
| Aptose Biosciences Inc | Fletcher Payne | FORMER SVP AND CFO | Sale or transfer of securities back to the company at price $ 1.73 per share. | 30 Jun 2026 | 22 | 0 (0%) | 0% | 1.7 | 38 | Common Shares |
| Aptose Biosciences Inc | Fletcher Payne | Sr VP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 55,000 | 55,000 | - | - | Employee Stock Option (Right to Buy) |